← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일

현재 선택: 1 · 임상 갱신 필요 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV21행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTStandard DatabasestaleApproved
Aspirin plus clopidogrel (Aspirin plus clopidogrel)
University of Florida·Coronary Arterial Disease (CAD)
31 trials
Overview
Program
Aspirin plus clopidogrel
Overview
Company
University of Florida
Overview
Modality
CGT
Overview
Target
Coronary Arterial Disease (CAD)
Overview
Indication
Coronary Arterial Disease (CAD)
Overview
Phase
APPROVED
Overview
Status
RECRUITING
Overview
Content status
Standard Database
Overview
Data Confidence
Data Confidence · Medium
Overview
Development Signal
Development Signal · Established
Overview
Approval status
Approved (flag incomplete)
MoA
Mechanism
targeting the P2Y12 receptor
PK/PD
Species
Rat
PK/PD
Animal (cat.)
Rat
PK/PD
Experiment
Pharmacokinetic
Toxicology
Species
Rat
Toxicology
Animal (cat.)
Rat
Toxicology
Major finding
Indobufen versus aspirin in dual antiplatelet therapy: a retrospective study of effects on serum uric acid levels and gout attacks in patients post-coronary stenting.. This retrospective study compared the effects of indobufen versus aspirin, each combined with clopidogrel, on serum uric acid (SUA) levels and gout attacks in patients undergoing coronary stenting. Among 213 enrolled patients, 156 w…
Clinical
Safety signal
Indobufen versus aspirin in dual antiplatelet therapy: a retrospective study of effects on serum uric acid levels and gout attacks in patients post-coronary stenting.. This retrospective study compared the effects of indobufen versus aspirin, each combined with clopidogrel, on serum uric acid (SUA) levels and gout attacks in patients undergoing coronary stenting. Among 213 enrolled patients, 156 w…
Clinical
Program phase
APPROVED
Preclinical
Animal (cat.)
Rat